๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Regulation of the Expression of the Prostate-specific Antigen by Claudin-7

โœ Scribed by J. -Y. Zheng; D. Yu; M. Foroohar; E. Ko; J. Chan; N. Kim; R. Chiu; S. Pang


Publisher
Springer
Year
2003
Tongue
English
Weight
351 KB
Volume
194
Category
Article
ISSN
0022-2631

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Expression of prostate-specific antigen
โœ Joanne N. Davis; Omer Kucuk; Fazlul H. Sarkar ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 260 KB

Prostate cancer is the second-leading cause of cancer-related deaths in men in the United States. Unfortunately, there is no effective therapy when prostate cancer becomes metastatic and refractory to conventional treatments. For this reason, the identification and exploration of new agents that red

Structure, function, and regulation of t
โœ H. Lilja ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› Springer-Verlag ๐ŸŒ English โš– 395 KB

Prostate-specific antigen (PSA) and human glandular kallikrein 1 (hGK-1) are structurally similar products of the human glandular kallikrein gene locus on chromosome 19 that become selectively expressed by human prostate tissue. PSA is one of the most abundant prostate-derived proteins in the semina

The use of prostate specific antigen den
โœ Paul R. Bretton; William P. Evans; James D. Borden; Ronald D. Castellanos ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 442 KB ๐Ÿ‘ 2 views

Background. Prostate specific antigen (PSA) is useful as a tumor marker for monitoring patients with prostate cancer after definitive therapy. Limitations have been noted when PSA was used for the early detection of prostate cancer. The use of prostate specific antigen density [PSAD = PSA (ng/ml)/pr

Radiotherapy for localized prostate carc
โœ Juanita M. Crook; Yasir A. Bahadur; R. Gregory Bociek; Gad A. Perry; Susan J. Ro ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 127 KB ๐Ÿ‘ 2 views

## Background: The objective of this study was to correlate the failure pattern of localized prostate carcinoma after radiotherapy (rt) with pretreatment (pretx) psa and post-rt nadir psa, using systematic biopsies and serum psa in the assessment of outcome. ## Methods: From january 1990 to febru

Prostate-specific antigen and diagnosing
โœ Joseph E. Oesterling ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 890 KB

Prostate-specific antigen is a kallikrein-like serine protease that is produced exclusively by the epithelial cells of all types of prostatic tissue, benign and malignant. Physiologically, it is present in the seminal fluid at high concentration and functions to cleave the high molecular weight prot